Through a new pilot program announced this week, the Food and Drug Administration will use artificial intelligence and cloud computing to monitor clinical trial data in real time, an effort that could ultimately shave years off the approval timelines for new drugs, devices and medications.FDA commissioner Marty Makary announced “the first ever real-time clinical trial” Tuesday at a press conference held at FDA’s headquarters in Silver Spring, Md. “Today is a milestone day for us to challenge the...